FDA Inspection
Remington Davis IncRemington Davis Inc – FDA Inspection, Jan 27, 2017
Record Details
This FDA Inspection record concerns Remington Davis Inc, with an inspection on January 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9008a8ef-3be7-4d89-9302-5009fbd908c5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1002423
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Remington Davis Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 10, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 22, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Remington Davis Inc
- FDA Inspection 1097339 - 2019-07-10
- FDA Inspection 1072627 - 2018-10-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.